oxidopamine has been researched along with Fractures, Bone in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Fractures, Bone: Breaks in bones.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahbaie, P | 1 |
| Li, WW | 1 |
| Guo, TZ | 1 |
| Shi, XY | 1 |
| Kingery, WS | 1 |
| Clark, JD | 1 |
1 other study available for oxidopamine and Fractures, Bone
| Article | Year |
|---|---|
Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Topics: Animals; Autonomic Nervous System; Chronic Pain; Complex Regional Pain Syndromes; Disease Models, An | 2022 |